Literature DB >> 10816527

Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis.

O C Turner1, A D Roberts, A A Frank, S W Phalen, D M McMurray, J Content, O Denis, S D'Souza, A Tanghe, K Huygen, I M Orme.   

Abstract

In this study, the hsp60 and hsp70 heat shock protein antigens of Mycobacterium tuberculosis were tested as potential vaccine candidates, using purified recombinant protein antigens or antigens encoded in the form of a DNA plasmid vaccine. Guinea pigs vaccinated with a mixture of the two proteins showed no evidence of resistance to low-dose aerosol challenge infection and quickly developed severe lung damage characterized by necrotizing bronchointerstitial pneumonia and bronchiolitis. As a result, we turned instead to a DNA vaccination approach using a plasmid encoding the hsp60 antigen of M. tuberculosis. Although immunogenic in mice, vaccination with plasmid DNA encoding hsp60 was not protective in that model or in the guinea pig model and again gave rise to similar severe lung damage. This study seriously questions the safety of vaccines against tuberculosis that target highly conserved heat shock proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816527      PMCID: PMC97658          DOI: 10.1128/IAI.68.6.3674-3679.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Authors:  J Turner; E R Rhoades; M Keen; J T Belisle; A A Frank; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  Stress proteins and the immune response.

Authors:  D B Young
Journal:  Antonie Van Leeuwenhoek       Date:  1990-10       Impact factor: 2.271

Review 3.  Chaperonins and the immune response.

Authors:  D B Young
Journal:  Semin Cell Biol       Date:  1990-02

4.  Reactivation of latent tuberculosis: variations on the Cornell murine model.

Authors:  C A Scanga; V P Mohan; H Joseph; K Yu; J Chan; J L Flynn
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG.

Authors:  T M Shinnick; D Sweetser; J Thole; J van Embden; R A Young
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG.

Authors:  J De Bruyn; R Bosmans; M Turneer; M Weckx; J Nyabenda; J P Van Vooren; P Falmagne; H G Wiker; M Harboe
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

7.  The mycobacterial GroEL stress protein: a common target of T-cell recognition in infection and autoimmunity.

Authors:  J R Lamb; V Bal; J B Rothbard; A Mehlert; P Mendez-Samperio; D B Young
Journal:  J Autoimmun       Date:  1989-06       Impact factor: 7.094

Review 8.  The immune response to mycobacterial heat shock proteins.

Authors:  D B Young
Journal:  Autoimmunity       Date:  1990       Impact factor: 2.815

9.  Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG.

Authors:  J De Bruyn; K Huygen; R Bosmans; M Fauville; R Lippens; J P Van Vooren; P Falmagne; M Weckx; H G Wiker; M Harboe
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

10.  Stress proteins may provide a link between the immune response to infection and autoimmunity.

Authors:  J R Lamb; V Bal; P Mendez-Samperio; A Mehlert; A So; J Rothbard; S Jindal; R A Young; D B Young
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

View more
  10 in total

1.  Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Authors:  Patcharaporn Tippayawat; Maneerat Pinsiri; Darawan Rinchai; Donporn Riyapa; Amornrat Romphruk; Yunn-Hwen Gan; Raymond L Houghton; Philip L Felgner; Richard W Titball; Mark P Stevens; Edouard E Galyov; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

2.  Tuberculosis vaccines: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

4.  Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.

Authors:  Alison J Johnson; Steven C Kennedy; Cecilia S Lindestam Arlehamn; Michael F Goldberg; Neeraj K Saini; Jiayong Xu; Sinu Paul; Subray S Hegde; John S Blanchard; John Chan; William R Jacobs; Alessandro Sette; Steven A Porcelli
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

Review 5.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis.

Authors:  Mark J Lyons; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide.

Authors:  M G Hartley; M Green; G Choules; D Rogers; D G C Rees; S Newstead; A Sjostedt; R W Titball
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

8.  Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Authors:  Jennifer L Taylor; Oliver C Turner; Randall J Basaraba; John T Belisle; Kris Huygen; Ian M Orme
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

9.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

10.  A second-generation anti TB vaccine is long overdue.

Authors:  Mauricio Castañón-Arreola; Yolanda López-Vidal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-06-03       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.